Luxbright AB stock analysis
Want to see SE:LXB full AI Analyst Report?
Luxbright AB (LXB) Stock Price & Analysis
LXB Stock Chart & Stats
- Day’s Range
- SEK 5.88 - SEK 6.00
- 52-Week Range
- SEK 3.20 - SEK 62.79
- Previous Close
- SEK 5.88
- Volume
- N/A
- Average Volume (3M)
- 558.00K
- Market Cap
- SEK 14.29M
- Enterprise Value
- SEK 19.88M
- Total Cash (Recent Filing)
- SEK 362.00K
- Total Debt (Recent Filing)
- SEK 3.24M
- Price to Earnings (P/E)
- ―
- Beta
- -0.39
- Next Earnings
- Feb 19, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage
Minimal debt and low leverage reduce financial pressure and preserve flexibility during the company’s development phase. A sizable equity cushion can help absorb operating losses and gives management more room to fund commercialization without the immediate burden of substantial interest or refinancing obligations.
Recent Revenue Acceleration
Sharp revenue acceleration in the two most recent annual periods indicates that Luxbright is making progress converting its technology into commercial activity. If this trajectory persists, a larger revenue base could improve operating leverage and provide a foundation for reducing losses over time.
Focused X-ray Technology
A focused product strategy around compact X-ray sources gives Luxbright a clearly defined technology and application base rather than a broadly dispersed offering. Serving industrial inspection and imaging use cases creates a durable platform for product commercialization, integration, and related support opportunities.
Bears Say
Persistent Losses
Large, persistent net losses and deeply negative operating results show that current revenue has not yet supported a profitable operating model. Continued losses can consume the company’s equity resources, delay self-funded growth, and make successful commercialization essential to improving long-term financial sustainability.
Negative Cash Generation
Materially negative operating cash flow means the business is consuming cash to fund ordinary operations rather than generating internal funding. Persistent free-cash-flow deficits may require external financing or balance-sheet resources, limiting strategic flexibility until revenue growth translates into cash profitability.
Unstable Margins
Volatile margins, including negative gross margin in multiple reported years, indicate that the cost structure has not yet become reliably scalable. This uncertainty makes future earnings harder to predict and means revenue growth may not translate into improved profitability without better cost control and operating leverage.
LXB FAQ
What was Luxbright AB’s price range in the past 12 months?
What is Luxbright AB’s market cap?
When is Luxbright AB’s upcoming earnings report date?
How were Luxbright AB’s earnings last quarter?
Is Luxbright AB overvalued?
Does Luxbright AB pay dividends?
What is Luxbright AB’s EPS estimate?
How many shares outstanding does Luxbright AB have?
What happened to Luxbright AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Luxbright AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Luxbright AB
Luxbright AB (publ), a technology-driven enterprise headquartered in Gothenburg, Sweden, specializes in engineering and marketing X-ray tubes, generators, and comprehensive X-ray systems. Established in 2012, the company's primary focus is on providing these advanced components to other system manufacturers.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Patrik Hallberg
- Employees
- 11
- Website
- www.luxbright.com
- Address
- Hulda Lindgrens gata 6B, Västra Frölunda, 421 31, SE
Luxbright AB (LXB) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 5 | 12 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 1 | 0 | 11 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| SE:PAXPaxman AB | ||
| SE:SCIBSciBase Holding AB | ||
| SE:SPECSpectraCure AB | ||
| SE:BACTI.BBactiguard Holding AB | ||
| SE:SDOSScandiDos AB |

